|
|
RNA-based drugs: discovery and design, From aptamers to oligonucleotides: a perspective for in silico approaches
Fabrice Leclerc
Doctoral. France. 2020
Lectures
hal-03313797v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Design of oligonucleotides as RNA-based drugs: prerequisites and opportunities for in silico methods within the framework of fragment-based approaches
Fabrice Leclerc
Mini-symposium@JOBIM 2020 - RNA structure, design and interactions with proteins, Jul 2020, Montpellier (en ligne), France
Conference papers
hal-03313254v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
MCSS with hybrid solvent models: qualitative docking & screening powers of nucleotidic ligands
Fabrice Leclerc
CHARMM Meeting 2020, Jul 2020, Cambridge, MA, United States
Conference papers
hal-03313271v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Modified oligonucleotides as RNA-based drugs (biosensors): prerequisites and opportunities for in silico methods within the framework of fragment-based approaches
Fabrice Leclerc
GDR RNA: 1st Scientific Meeting, Nov 2020, Nice (en ligne), France
Conference papers
hal-03313276v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genome dynamics of the Streptomyces genus
Jean-Noël Lorenzi
,
Olivier Lespinet
,
Pierre Leblond
,
Annabelle Thibessard
ACTINO 2020 - Journées des actinobactéries, Dec 2020, Gif-sur-Yvette, France
Conference papers
hal-03060006v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|